Global Insomnia Therapeutics Market Analysis and Forecast 2025 – 2035
Rising insomnia prevalence worldwide, driven by stress, lifestyle changes, and aging populations, boosts demand for effective treatments.Orexin receptor antagonists are the fastest-growing drug segment due to improved safety and efficacy over traditional therapies.Behavioural therapies, especially digital cognitive behavioural therapy for insomnia (CBT-I), are gaining popularity as non-drug treatment options.North America dominates the market with advanced healthcare infrastructure and early adoption of innovativeinsomnia therapies.